ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ExtraPace
|
128 |
53K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
128
|
53K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
152 |
32K |
19 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
152
|
32K
|
19
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
562K |
3 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
1.4K
|
562K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
ExtraPace
|
963 |
344K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
963
|
344K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
ExtraPace
|
963 |
344K |
5 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
963
|
344K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
152 |
32K |
16 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
152
|
32K
|
16
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ExtraPace
|
128 |
53K |
29 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
128
|
53K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
152 |
32K |
27 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
152
|
32K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
152 |
32K |
16 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
152
|
32K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
152 |
32K |
30 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
152
|
32K
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
7 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
24K
|
11M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
10 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
24K
|
11M
|
10
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ExtraPace
|
128 |
53K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
128
|
53K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
24K
|
11M
|
7
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Change in substantial holding
|
|
ExtraPace
|
5 |
2.4K |
13 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
5
|
2.4K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ExtraPace
|
128 |
53K |
10 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
128
|
53K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
ExtraPace
|
14K |
6.6M |
10 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
14K
|
6.6M
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
18 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
510
|
117K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
ExtraPace
|
159 |
71K |
23 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
159
|
71K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
17 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
510
|
117K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
21 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
510
|
117K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
20 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
510
|
117K
|
20
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
562K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.4K
|
562K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ExtraPace
|
152 |
58K |
17 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
152
|
58K
|
17
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ExtraPace
|
152 |
58K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
152
|
58K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
13 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
24K
|
11M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
10 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
24K
|
11M
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
35 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
510
|
117K
|
35
|
|
ASX - By Stock
|
SYR Lithium |
Re:
SYR Charts
|
|
ExtraPace
|
3.3K |
1.5M |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
3.3K
|
1.5M
|
7
|
|
ASX - By Stock
|
SYR Lithium |
Re:
SYR Charts
|
|
ExtraPace
|
3.3K |
1.5M |
3 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
3.3K
|
1.5M
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Pharmaust Investor Update
|
|
ExtraPace
|
20 |
5.5K |
25 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
20
|
5.5K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
23 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
24K
|
11M
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
16 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
510
|
117K
|
16
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ExtraPace
|
152 |
58K |
22 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
152
|
58K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
23 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
510
|
117K
|
23
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Managing Director's AGM Presentation
|
|
ExtraPace
|
10 |
4.5K |
19 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
10
|
4.5K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
5 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
24K
|
11M
|
5
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
562K |
16 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
1.4K
|
562K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
12 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
510
|
117K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
14 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
510
|
117K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
510
|
117K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
16 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
510
|
117K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
20 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
510
|
117K
|
20
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
ExtraPace
|
963 |
344K |
0 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
963
|
344K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
ExtraPace
|
86 |
20K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
4
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
562K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
1.4K
|
562K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
510 |
117K |
12 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
510
|
117K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
ExtraPace
|
222 |
47K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
222
|
47K
|
4
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
562K |
0 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
562K
|
0
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
562K |
10 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
562K
|
10
|
|